Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M67,664Revenue $M23,113Net Margin (%)20.3Z-Score4.3
Enterprise Value $M67,480EPS $4.3Operating Margin %23.2F-Score7
P/E(ttm))14.0Cash Flow Per Share $5.4Pre-tax Margin (%)25.5Higher ROA y-yY
Price/Book3.810-y EBITDA Growth Rate %12.7Quick Ratio1.1Cash flow > EarningsY
Price/Sales2.95-y EBITDA Growth Rate %0.4Current Ratio1.5Lower Leverage y-yY
Price/Cash Flow9.1y-y EBITDA Growth Rate %8.6ROA % (ttm)13.3Higher Current Ratio y-yN
Dividend Yield %3.2Insider Buy (3m)0ROE % (ttm)26.6Less Shares Outstanding y-yY
Payout Ratio %54.0Shares Outstanding M1,127ROI % (ttm)23.7Gross Margin Increase y-yN

Gurus Latest Trades with LLY

Number of guru portfolios checked: 54.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
LLYVanguard Health Care Fund 2013-12-31 Add0.67%$47.65 - $51.34
($50.05)
$ 60.4321%Add 22.98%22,895,000
LLYCharles Brandes 2013-12-31 Add0.19%$47.65 - $51.34
($50.05)
$ 60.4321%Add 12.57%2,711,949
LLYJoel Greenblatt 2013-12-31 Add0.11%$47.65 - $51.34
($50.05)
$ 60.4321%Add 201.79%141,121
LLYRay Dalio 2013-12-31 Add0.01%$47.65 - $51.34
($50.05)
$ 60.4321%Add 153.37%48,239
LLYVanguard Health Care Fund 2013-09-30 Add0.46%$49.92 - $54.96
($52.42)
$ 60.4315%Add 16.91%18,617,000
LLYCharles Brandes 2013-09-30 Add0.23%$49.92 - $54.96
($52.42)
$ 60.4315%Add 16.93%2,409,134
LLYPRIMECAP Management 2013-09-30 Add0.13%$49.92 - $54.96
($52.42)
$ 60.4315%Add 3.98%50,846,997
LLYDavid Dreman 2013-09-30 Buy 0.02%$49.92 - $54.96
($52.42)
$ 60.4315%New holding, 4290 sh.4,290
LLYRay Dalio 2013-09-30 Buy 0.01%$49.92 - $54.96
($52.42)
$ 60.4315%New holding, 19039 sh.19,039
LLYJohn Hussman 2013-09-30 Reduce-1.58%$49.92 - $54.96
($52.42)
$ 60.4315%Reduce -98.57%10,000
LLYJohn Hussman 2013-06-30 Add0.23%$49.06 - $58.33
($54.41)
$ 60.4311%Add 16.64%701,000
LLYPRIMECAP Management 2013-06-30 Add0.14%$49.06 - $58.33
($54.41)
$ 60.4311%Add 4.39%48,900,865
LLYJoel Greenblatt 2013-06-30 Add0.07%$49.06 - $58.33
($54.41)
$ 60.4311%Add 894.98%39,411
LLYGeorge Soros 2013-06-30 Sold Out -0.04%$49.06 - $58.33
($54.41)
$ 60.4311%Sold Out0
LLYJoel Greenblatt 2013-03-31 Buy 0.01%$49.32 - $56.79
($53.91)
$ 60.4312%New holding, 3961 sh.3,961
LLYJohn Hussman 2013-03-31 Reduce-1.03%$49.32 - $56.79
($53.91)
$ 60.4312%Reduce -57.1%601,000
LLYGeorge Soros 2013-03-31 Reduce-0.03%$49.32 - $56.79
($53.91)
$ 60.4312%Reduce -45%55,000
LLYRay Dalio 2013-03-31 Sold Out -0.01%$49.32 - $56.79
($53.91)
$ 60.4312%Sold Out0
LLYJoel Greenblatt 2012-12-31 Sold Out -0.1%$45.91 - $53.81
($49.24)
$ 60.4323%Sold Out0
LLYGeorge Soros 2012-12-31 Reduce-0.07%$45.91 - $53.81
($49.24)
$ 60.4323%Reduce -47.37%100,000
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

LLY is held by these Gurus:

Ticker Guru Name Portfolio Date* Current Shares % of Shares Outstanding % of Total Assets Managed Change from Last Holdings Holding History
LLY Joel Greenblatt 2013-12-31141,1210.010.17+201.79%
LLY Ray Dalio 2013-12-3148,23900.02+153.37%
LLY Vanguard Health Care Fund 2013-12-3122,895,0002.033.6+22.98%
LLY Charles Brandes 2013-12-312,711,9490.241.7+12.57%
LLY David Dreman 2013-12-314,76000.02+10.96%
LLY PRIMECAP Management 2013-12-3151,548,4254.583.2+1.38%
LLY John Hussman 2013-12-3110,00000.04
LLY Dodge & Cox 2013-12-3135,76000
LLY Mario Gabelli 2013-12-31123,9000.010.03-0.48%
Premium Most recent portfolio changes are included for Premium Members only!


LLY: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
LILLY ELI & CO10% Owner 2014-04-15Buy733,445$7763.29view
Conterno Enrique ASr. VP & Pres., Lilly Diabetes 2013-08-15Sell5,000$53.7912.34view
Tapiero JacquesSVP&Pres., Emerging Markets 2013-07-29Sell7,500$53.7412.45view
Conterno Enrique ASr. VP & Pres., Lilly Diabetes 2013-07-15Sell5,000$51.4317.5view
Conterno Enrique ASr. VP & Pres., Lilly Diabetes 2013-06-17Sell5,000$52.4515.21view
Conterno Enrique ASr. VP & Pres., Lilly Diabetes 2013-05-15Sell5,000$56.157.62view
Simmons Jeffrey NSVP&Pres.,Elanco Animal Health 2013-05-10Sell10,000$54.4910.9view
Mahony SusanSVP & Pres., Lilly Oncology 2013-04-29Sell3,500$56.337.28view
Conterno Enrique ASr. VP & Pres., Lilly Diabetes 2013-04-15Sell5,000$57.15.83view
Mahony SusanSVP & Pres., Lilly Oncology 2013-03-26Sell5,000$567.91view

Press Releases about LLY :

Quarterly/Annual Reports about LLY:

News about LLY:

Articles On GuruFocus.com
Forest Laboratories' Recovery Mar 18 2014 
AstraZeneca: Time to Make a Bet? Steven Cohen Seems to Think It Is Jan 15 2014 
Guru Stocks at 52-Week Lows: IBM, T, TLK, LLY, GLD Dec 16 2013 
Johnson & Johnson (JNJ) Dividend Stock Analysis Nov 21 2013 
Prolific Selling - Hussman’s High-Impact Moves Mirror Insiders Nov 05 2013 
Abbvie Inc. (ABBV) Dividend Stock Analysis Sep 27 2013 
Renaissance Man Jim Simons - A Tale of Three Pharmaceuticals and Remarkable Gains Jul 21 2013 
Johnson & Johnson (JNJ) Dividend Stock Analysis May 23 2013 
20 Best-Yielding Health Care Stocks - Less Volatile Than the Market Apr 02 2013 
Abbvie Inc. (ABBV) Dividend Stock Analysis Mar 22 2013 

More From Our Partners
Eli Lilly/ Boehringer Drug Under FDA Review - Analyst Blog Apr 15 2014 - ZACKS

Add Notes, Comments or Ask Questions

User Comments

No comment yet
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK
Hide